{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:00:12Z","timestamp":1791388812828,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010822"],"award-info":[{"award-number":["2025A1515010822"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s13555-026-01675-4","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T01:52:20Z","timestamp":1771811540000},"page":"1779-1794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathological Insights into the Limitations of Clinical and Dermoscopic Evaluations in Monitoring Sonidegib Treatment Response for Locally Advanced Basal Cell Carcinoma: A Real-World Study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0797-4852","authenticated-orcid":false,"given":"Xurong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jipang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-9164","authenticated-orcid":false,"given":"Renliang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"5","key":"1675_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069\u201380.","journal-title":"Br J Dermatol"},{"key":"1675_CR2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11314.1","volume":"6","author":"M Totonchy","year":"2017","unstructured":"Totonchy M, Leffell D. Emerging concepts and recent advances in basal cell carcinoma. F1000Res. 2017;6:2085.","journal-title":"F1000Res"},{"key":"1675_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2017.12.009","volume":"64","author":"MR Migden","year":"2018","unstructured":"Migden MR, Chang ALS, Dirix L, Stratigos AJ, Lear JT. Emerging trends in the treatment of advanced basal cell carcinoma. Cancer Treat Rev. 2018;64:1\u201310.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"1675_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/bjc.2014.270","volume":"111","author":"JT Lear","year":"2014","unstructured":"Lear JT, Corner C, Dziewulski P, et al. Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective. Br J Cancer. 2014;111(8):1476\u201381.","journal-title":"Br J Cancer"},{"key":"1675_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216821","volume":"589","author":"MH Idriss","year":"2024","unstructured":"Idriss MH, Stull CM, Migden MR. Treatments on the horizon for locally advanced basal cell carcinoma. Cancer Lett. 2024;589:216821.","journal-title":"Cancer Lett"},{"issue":"9","key":"1675_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/jdv.16230","volume":"34","author":"R Dummer","year":"2020","unstructured":"Dummer R, Ascierto PA, Basset-Seguin N, et al. Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion. J Eur Acad Dermatol Venereol. 2020;34(9):1944\u201356.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1675_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","volume":"118","author":"K Peris","year":"2019","unstructured":"Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer. 2019;118:10\u201334.","journal-title":"Eur J Cancer"},{"key":"1675_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143621","author":"G Nazzaro","year":"2023","unstructured":"Nazzaro G, Benzecry V, Mattioli MA, et al. Sonidegib in locally advanced basal cell carcinoma: a monocentric retrospective experience and a review of published real-life data. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15143621.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1675_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara JA, Monge C, Yang Y, Takebe N. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2020;17(4):204\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-physiol-022516-034202","volume":"79","author":"CM Mistretta","year":"2017","unstructured":"Mistretta CM, Kumari A. Tongue and taste organ biology and function: homeostasis maintained by hedgehog signaling. Annu Rev Physiol. 2017;79:335\u201356.","journal-title":"Annu Rev Physiol"},{"issue":"6","key":"1675_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/bjd.18552","volume":"182","author":"R Dummer","year":"2020","unstructured":"Dummer R, Guminksi A, Gutzmer R, et al. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase\u00a0II randomized, double-blind BOLT study. Br J Dermatol. 2020;182(6):1369\u201378.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1675_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s13555-020-00378-8","volume":"10","author":"A Villani","year":"2020","unstructured":"Villani A, Fabbrocini G, Costa C, Scalvenzi M. Sonidegib: safety and efficacy in treatment of advanced basal cell carcinoma. Dermatol Ther (Heidelb). 2020;10(3):401\u201312.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"1675_CR13","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1097\/CM9.0000000000003444","volume":"138","author":"J Luan","year":"2025","unstructured":"Luan J, He R, Zhu Q, et al. Efficacy and safety of sonidegib in the treatment of locally advanced basal cell carcinoma: a multicenter retrospective experience in real-world China. Chin Med J (Engl). 2025;138(12):1508\u20139.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"1675_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/bjd\/ljae187","volume":"191","author":"S Zhang","year":"2024","unstructured":"Zhang S, Ran M. Deceptive pigment changes in neoadjuvant\u00a0sonidegib therapy for basal\u00a0cell\u00a0carcinoma. Br J Dermatol. 2024;191(3):472\u20133.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1675_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","volume":"16","author":"MR Migden","year":"2015","unstructured":"Migden MR, Guminski A, Gutzmer R, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase\u00a02 trial. Lancet Oncol. 2015;16(6):716\u201328.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1675_CR16","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jaad.2020.08.042","volume":"84","author":"R Dummer","year":"2021","unstructured":"Dummer R, Lear JT, Guminski A, Leow LJ, Squittieri N, Migden M. Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: results from the final analysis of the randomized phase\u00a02 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42\u00a0months. J Am Acad Dermatol. 2021;84(4):1162\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1675_CR17","first-page":"167","volume":"88","author":"AG Marzuka","year":"2015","unstructured":"Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88(2):167\u201379.","journal-title":"Yale J Biol Med"},{"key":"1675_CR18","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.2740","volume":"102","author":"LJ Leow","year":"2022","unstructured":"Leow LJ, Howard V. Clinical clearance following improvement of histologic subtype of basal cell carcinoma with Sonidegib. Acta Dermato-Venereol. 2022;102:adv00809.","journal-title":"Acta Dermato-Venereol"},{"issue":"3","key":"1675_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s13555-021-00533-9","volume":"11","author":"A Villani","year":"2021","unstructured":"Villani A, Fabbrocini G, Costa C, Scalvenzi M. Reflectance confocal microscopy identification of subclinical basal cell carcinoma after vismodegib treatment: report of a case. Dermatol Ther (Heidelb). 2021;11(3):1071\u20134.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"1675_CR20","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jaad.2018.12.026","volume":"80","author":"O Reiter","year":"2019","unstructured":"Reiter O, Mimouni I, Gdalevich M, et al. The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(5):1380\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1675_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113254","volume":"192","author":"K Peris","year":"2023","unstructured":"Peris K, Fargnoli MC, Kaufmann R, et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer. 2023;192:113254.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1675_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3892\/etm.2021.10982","volume":"23","author":"E Niculet","year":"2022","unstructured":"Niculet E, Craescu M, Rebegea L, et al. Basal cell carcinoma: comprehensive clinical and histopathological aspects, novel imaging tools and therapeutic approaches (review). Exp Ther Med. 2022;23(1):60.","journal-title":"Exp Ther Med"},{"key":"1675_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/349726","volume":"2011","author":"LM Frey","year":"2011","unstructured":"Frey LM, Houben R, Br\u00f6cker EB. Pigmentation, melanocyte colonization, and p53 status in basal cell carcinoma. J Skin Cancer. 2011;2011:349726.","journal-title":"J Skin Cancer"},{"key":"1675_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054360","author":"L Guo","year":"2023","unstructured":"Guo L, Li W, Gu Z, et al. Recent advances and progress on melanin: from source to application. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054360.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1675_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/skinhd\/vzae025","volume":"5","author":"S Cappilli","year":"2025","unstructured":"Cappilli S, Mannino M, Palmisano G, et al. Locally advanced basal cell carcinoma treated with sonidegib: in vivo monitoring with line-field confocal optical coherence tomography. Skin Health Dis. 2025;5(1):37\u201340.","journal-title":"Skin Health Dis"},{"issue":"5","key":"1675_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/jdv.19806","volume":"38","author":"C Cantisani","year":"2024","unstructured":"Cantisani C, Musolff N, Longo C, et al. Dynamic optical coherence tomography evaluation in locally advanced basal cell carcinoma during sonidegib treatment. J Eur Acad Dermatol Venereol. 2024;38(5):967\u201373.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1675_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175087","author":"I Proietti","year":"2024","unstructured":"Proietti I, Filippi L, Bagni O, Potenza C. Metabolic imaging of advanced basal cell carcinoma treated with sonidegib: a retrospective case series study. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13175087.","journal-title":"J Clin Med"},{"issue":"5","key":"1675_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/jdv.14650","volume":"32","author":"C Couzan","year":"2018","unstructured":"Couzan C, Cinotti E, Labeille B, et al. Reflectance confocal microscopy identification of subclinical basal cell carcinomas during and after vismodegib treatment. J Eur Acad Dermatol Venereol. 2018;32(5):763\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1675_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdcr.2022.07.032","volume":"28","author":"R Zhao","year":"2022","unstructured":"Zhao R, Wang B, Lowe L, Dlugosz A, Bichakjian CK. Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma. JAAD Case Rep. 2022;28:54\u20137.","journal-title":"JAAD Case Rep"},{"issue":"5","key":"1675_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jamadermatol.2015.4330","volume":"152","author":"SV Mohan","year":"2016","unstructured":"Mohan SV, Chang J, Li S, Henry AS, Wood DJ, Chang AL. Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma. JAMA Dermatol. 2016;152(5):527\u201332.","journal-title":"JAMA Dermatol"},{"issue":"17","key":"1675_CR31","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1158\/0008-5472.CAN-14-2999-T","volume":"75","author":"X Zhao","year":"2015","unstructured":"Zhao X, Ponomaryov T, Ornell KJ, et al. RAS\/MAPK activation drives resistance to Smo inhibition, metastasis, and tumor evolution in Shh pathway-dependent tumors. Cancer Res. 2015;75(17):3623\u201335.","journal-title":"Cancer Res"},{"issue":"4","key":"1675_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jaad.2017.03.038","volume":"77","author":"T Bhutani","year":"2017","unstructured":"Bhutani T, Abrouk M, Sima CS, et al. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. J Am Acad Dermatol. 2017;77(4):713\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1675_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104066","volume":"189","author":"P Bossi","year":"2023","unstructured":"Bossi P, Ascierto PA, Basset-Seguin N, et al. Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors. Crit Rev Oncol Hematol. 2023;189:104066.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1675_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15060226","author":"A Paradisi","year":"2025","unstructured":"Paradisi A, Mannino M, Brunetti F, Bocchino E, Di Stefani A, Peris K. Advanced basal cell carcinoma: a narrative review on current systemic treatments and the neoadjuvant approach. J Pers Med. 2025. https:\/\/doi.org\/10.3390\/jpm15060226.","journal-title":"J Pers Med"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01675-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:05:38Z","timestamp":1774371938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01675-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01675-4","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xurong Liu, Jipang Zhan, Jingwen Zou, Rongyi Chen, Jing Zhong, and Renliang He have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Institutional Review Board of Dermatology Hospital of Southern Medical University (Approval No. IIT-2025-065) and conducted in accordance with the Declaration of Helsinki and ICH-GCP guidelines. Written informed consent was obtained from all patients. The patients in this manuscript provided written informed consent for publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}